Moelis & CompanyMCNYSE
Loading
Moelis & Company is an independent investment bank providing M&A advisory, restructuring, and capital markets services to corporations, governments, and financial sponsors globally. The firm operates with minimal balance sheet risk, generating fees from transaction completion rather than principal investing. With 1,100+ professionals across 20+ offices, Moelis competes against bulge bracket banks and boutiques like Evercore, Lazard, and PJT Partners on complex, high-value advisory mandates.
Moelis earns success fees tied to transaction completion, typically 0.5-2.0% of deal value for M&A (higher for smaller deals, lower for mega-deals). Restructuring generates monthly retainers plus success fees upon plan confirmation or transaction close. The model requires minimal capital investment—primary costs are compensation (typically 55-65% of revenue) and office infrastructure. Competitive advantage stems from senior banker relationships, sector expertise (particularly in energy, healthcare, technology), and independence from lending conflicts that constrain universal banks. The partnership structure aligns employee incentives with deal origination.
Global M&A transaction volume and average deal size—directly drives advisory fee pool
Credit market conditions and high-yield spreads—tighter spreads reduce restructuring activity, wider spreads increase it
CEO confidence and corporate cash deployment appetite—drives strategic M&A activity
Equity market volatility (VIX)—extreme volatility can freeze M&A markets, moderate volatility supports activity
Quarterly revenue beat/miss versus consensus—highly variable quarterly results create earnings surprise sensitivity
Secular decline in investment banking fees as percentage of deal value—increased competition from boutiques and in-house corporate development teams compressing fee rates, particularly on mega-deals
Regulatory restrictions on conflicts of interest—potential limitations on advising both buyers and sellers, or restrictions on advising clients where the firm has equity stakes
Technology disruption in lower-middle market—AI-driven deal sourcing and valuation tools could commoditize advisory services for sub-$500M transactions
Bulge bracket banks (Goldman Sachs, Morgan Stanley, JPMorgan) leveraging balance sheet capabilities to win mandates by offering integrated financing solutions that independent advisors cannot match
Talent poaching and team departures—senior banker defections to competitors or new boutique formations can result in immediate revenue loss and client relationship transfers
Private equity in-house advisory teams—large sponsors (Blackstone, KKR, Apollo) building internal M&A capabilities to reduce external advisory spend
Low current ratio (0.61) reflects typical investment banking working capital structure with quarterly bonus accruals and timing of fee collections—not a liquidity concern given strong operating cash flow generation
Moderate debt/equity (0.50) used primarily for share repurchases and dividend funding—manageable given asset-light model and $400M annual free cash flow
Partnership equity redemption obligations—as senior partners retire, the firm must fund equity buyouts, creating periodic cash demands
high - Investment banking advisory is highly procyclical. M&A activity correlates strongly with CEO confidence, equity valuations, and credit availability. During expansions (2021-2022), M&A volumes surge as companies pursue growth through acquisitions and private equity deploys record dry powder. Recessions typically see 30-50% declines in M&A volumes as strategic uncertainty rises and financing becomes scarce. However, restructuring advisory provides partial offset during downturns, creating asymmetric but still cyclical exposure. The 27% revenue growth and 71% net income growth reflect the 2024-2025 recovery in deal activity from 2023 lows.
Rising rates have dual effects: (1) Negative for M&A—higher discount rates reduce acquisition valuations and increase financing costs, dampening deal activity, particularly for leveraged buyouts. The 2022-2023 rate surge caused M&A volumes to decline 40%+ from 2021 peaks. (2) Positive for restructuring—higher rates stress overleveraged balance sheets, creating advisory opportunities in debt exchanges, bankruptcy proceedings, and liability management. Net effect is typically negative in early rate-hike cycles, potentially positive if rates stay elevated long enough to trigger distress wave.
High sensitivity to credit market conditions. Wide high-yield spreads (above 500bps) signal risk aversion that freezes M&A financing but creates restructuring opportunities. Tight spreads (below 300bps) facilitate leveraged M&A but reduce restructuring demand. The firm has no direct lending exposure or credit losses—impact is purely through client activity levels. Current spread environment (estimated 350-400bps in early 2026) represents moderate conditions supporting balanced M&A and restructuring mix.
value with cyclical timing focus - The stock attracts investors seeking exposure to M&A cycle recovery at depressed valuations. Current 3.1x P/S and 8.8x P/B are below historical peaks (5-6x P/S in strong M&A years), appealing to value investors betting on deal volume normalization. The 8.9% FCF yield and capital return program (dividends plus buybacks) attract income-focused value investors. However, extreme earnings volatility (71% net income growth this period) deters pure dividend investors. Hedge funds and tactical allocators use the stock for cyclical positioning around M&A inflection points.
high - Investment banking advisory stocks exhibit 30-40% annual volatility due to quarterly revenue lumpiness (large deals can shift between quarters) and sensitivity to macro sentiment shifts. Beta to financial sector typically 1.2-1.5x. The -18.5% one-year return and -12% six-month return reflect ongoing uncertainty about M&A cycle sustainability despite recent revenue growth. Stock can move 10-15% on earnings releases due to high estimate dispersion and quarterly result unpredictability.